Du, Fang-Zhi
Wu, Min-Zhi
Zhang, Xu
Zhang, Rui-Li
Wang, Qian-Qiu http://orcid.org/0000-0003-0654-3826
Funding for this research was provided by:
National Natural Science Foundation of China (81772209, 81601804)
Project of Wuxi Science and Technology Bureau (N20192021)
CAMS Innovation Fund for Medical Sciences (CIFMS-2021-I2M-1-001)
Article History
Received: 8 December 2021
Accepted: 18 September 2022
First Online: 1 October 2022
Declarations
:
: The trial protocol was reviewed and approved by the Medical Ethics Committee of the Chinese Academy of Medical Sciences Institute of Dermatology and the National Centre for STD Control in Nanjing (approval number: 2020-KY-022). If any modifications are made, amendments will be reviewed and approved by the ethics committee. Two copies of written informed consent should be signed from each patient before enrolment in the study; one copy will be for the participant and the other for the investigator.
: Not applicable.
: The authors declare no competing interests.